688321 微芯生物
已收盘 12-05 15:00:00
资讯
新帖
简况
微芯生物（688321）披露以集中竞价交易方式首次回购公司股份，12月03日股价下跌2.75%
证券之星 · 12-03 22:17
微芯生物（688321）披露以集中竞价交易方式首次回购公司股份，12月03日股价下跌2.75%
微芯生物(688321.SH)定增股票申请获得中国证监会同意注册批复
智通财经 · 12-02
微芯生物(688321.SH)定增股票申请获得中国证监会同意注册批复
微芯生物（688321）披露关于股份回购进展公告，12月01日股价下跌0.5%
证券之星 · 12-01
微芯生物（688321）披露关于股份回购进展公告，12月01日股价下跌0.5%
微芯生物（688321）披露拟延长定增决议有效期，11月27日股价上涨0.04%
证券之星 · 11-27
微芯生物（688321）披露拟延长定增决议有效期，11月27日股价上涨0.04%
11月26日微芯生物现7笔折价12.98%的大宗交易 合计成交4919.68万元
证券之星 · 11-26
11月26日微芯生物现7笔折价12.98%的大宗交易 合计成交4919.68万元
11月24日微芯生物现12笔折价13.24%的大宗交易 合计成交4446.72万元
证券之星 · 11-24
11月24日微芯生物现12笔折价13.24%的大宗交易 合计成交4446.72万元
每周股票复盘：微芯生物（688321）股东减持1.18%且公司拟取消监事会
证券之星 · 11-23
每周股票复盘：微芯生物（688321）股东减持1.18%且公司拟取消监事会
11月20日微芯生物发生1笔大宗交易 成交金额2000万元
证券之星 · 11-20
11月20日微芯生物发生1笔大宗交易 成交金额2000万元
11月19日微芯生物现4笔大宗交易 机构净买入1255.5万元
证券之星 · 11-19
11月19日微芯生物现4笔大宗交易 机构净买入1255.5万元
每周股票复盘：微芯生物（688321）现两日大宗交易合计超5300万元
证券之星 · 11-16
每周股票复盘：微芯生物（688321）现两日大宗交易合计超5300万元
11月14日微芯生物现6笔折价12.73%的大宗交易 合计成交2291.52万元
证券之星 · 11-14
11月14日微芯生物现6笔折价12.73%的大宗交易 合计成交2291.52万元
11月13日微芯生物现9笔折价13.63%的大宗交易 合计成交3075.33万元
证券之星 · 11-13
11月13日微芯生物现9笔折价13.63%的大宗交易 合计成交3075.33万元
每周股票复盘：微芯生物（688321）西格列他钠产能建设进展及临床研究突破
证券之星 · 11-09
每周股票复盘：微芯生物（688321）西格列他钠产能建设进展及临床研究突破
微芯生物(688321.SH)：西奥罗尼胶囊治疗转移性胰腺导管腺癌临床试验申请获受理
智通财经 · 11-06
微芯生物(688321.SH)：西奥罗尼胶囊治疗转移性胰腺导管腺癌临床试验申请获受理
微芯生物：11月3日进行路演，国盛证券、方正证券等多家机构参与
证券之星 · 11-05
微芯生物：11月3日进行路演，国盛证券、方正证券等多家机构参与
每周股票复盘：微芯生物（688321）股东户数增25.25%，净利增238.53%
证券之星 · 11-02
每周股票复盘：微芯生物（688321）股东户数增25.25%，净利增238.53%
微芯生物（688321）2025年三季报简析：营收净利润同比双双增长
证券之星 · 11-01
微芯生物（688321）2025年三季报简析：营收净利润同比双双增长
微芯生物(688321.SH)拟1000万元至1500万元回购股份
智通财经 · 10-31
微芯生物(688321.SH)拟1000万元至1500万元回购股份
10月31日微芯生物涨8.13%，中航优选领航混合发起A基金重仓该股
证券之星 · 10-31
10月31日微芯生物涨8.13%，中航优选领航混合发起A基金重仓该股
图解微芯生物三季报：第三季度单季净利润同比增长508.54%
证券之星 · 10-31
图解微芯生物三季报：第三季度单季净利润同比增长508.54%
加载更多
公司概况
公司名称：
深圳微芯生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2019-08-12
主营业务：
深圳微芯生物科技股份有限公司的主营业务是药物技术开发、相关成果商业应用；新药研究、开发、技术转让及其它有关的服务；新治疗技术研究、开发、技术转让及其它有关的服务；对外专利、技术的许可授权；药品的生产；保健食品生产经营。公司的主要产品是爱谱沙（西达本胺）、双洛平（西格列他钠）、西奥罗尼、CS23546、CS231295、CS32582、其他在研产品。
发行价格：
20.43
{"stockData":{"symbol":"688321","market":"SH","secType":"STK","nameCN":"微芯生物","latestPrice":27.65,"timestamp":1764918000000,"preClose":27.31,"halted":0,"volume":5184677,"delay":0,"changeRate":0.0124,"floatShares":408000000,"shares":408000000,"eps":0.0179,"marketStatus":"已收盘","change":0.34,"latestTime":"12-05 15:00:00","open":27.3,"high":27.68,"low":26.89,"amount":141000000,"amplitude":0.0289,"askPrice":27.65,"askSize":24,"bidPrice":27.64,"bidSize":54,"shortable":0,"etf":0,"ttmEps":0.0179,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":27.31,"symbolType":"stock_kcb","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":30.04,"lowLimit":24.58,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":407807559,"isCdr":false,"pbRate":7.36,"roa":"--","peRate":1544.692737,"roe":"4.37%","epsLYR":-0.2808,"committee":-0.507805,"marketValue":11276000000,"turnoverRate":0.0127,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-08。","afterMarket":{"amount":8820.35,"volume":319,"close":27.65,"buyVolume":0,"sellVolume":0,"time":1764920037768,"indexStatus":"已收盘 12-05 15:30:00","preClose":27.31},"floatMarketCap":11276000000},"requestUrl":"/m/hq/s/688321","defaultTab":"news","newsList":[{"id":"2588004422","title":"微芯生物（688321）披露以集中竞价交易方式首次回购公司股份，12月03日股价下跌2.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588004422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588004422?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:17","pubTimestamp":1764771441,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，微芯生物报收于26.92元，较前一交易日下跌2.75%，最新总市值为109.78亿元。根据公司近日发布的公告，2025年12月3日，深圳微芯生物科技股份有限公司通过集中竞价交易方式首次回购股份111,121股，占公司总股本的0.03%，回购价格区间为26.8元/股至27元/股，支付资金总额2,990,977.1元。本次回购股份用于员工持股计划或股权激励，回购期限为2025年10月30日至2026年10月29日，回购金额预计为1,000万元至1,500万元。本次回购符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300040278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2588508044","title":"微芯生物(688321.SH)定增股票申请获得中国证监会同意注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2588508044","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588508044?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:40","pubTimestamp":1764661248,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微芯生物(688321.SH)发布公告，公司于近日收到中国证券监督管理委员会出具的《关于同意深圳微芯生物科技股份有限公司向特定对象发行股票注册的批复》，同意公司向特定对象发行股票的注册申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2588775520","title":"微芯生物（688321）披露关于股份回购进展公告，12月01日股价下跌0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588775520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588775520?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:26","pubTimestamp":1764599162,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，微芯生物报收于27.95元，较前一交易日下跌0.5%，最新总市值为113.98亿元。该股当日开盘27.96元，最高28.22元，最低27.73元，成交额达2.01亿元，换手率为1.77%。截至2025年11月30日，公司尚未实施回购，未有实际回购股份及金额。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2586822530","title":"微芯生物（688321）披露拟延长定增决议有效期，11月27日股价上涨0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586822530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586822530?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:19","pubTimestamp":1764253158,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，微芯生物报收于27.82元，较前一交易日上涨0.04%，最新总市值为113.45亿元。该股当日开盘27.8元，最高28.18元，最低27.4元，成交额达1.67亿元，换手率为1.47%。近日，微芯生物发布《2025年第一次临时股东大会会议资料》，公告显示公司拟召开2025年第一次临时股东大会，审议关于延长2024年度向特定对象发行A股股票相关决议及授权有效期12个月至2026年12月5日的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2586585842","title":"11月26日微芯生物现7笔折价12.98%的大宗交易 合计成交4919.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586585842","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586585842?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:52","pubTimestamp":1764150755,"startTime":"0","endTime":"0","summary":"证券之星消息，11月26日微芯生物发生大宗交易，交易数据如下：近三个月该股共发生43笔大宗交易，合计成交8.16万手，折价成交43笔。该股近期无解禁股上市。截至2025年11月26日收盘，微芯生物(688321)报收于27.81元，上涨1.5%，换手率2.38%，成交量9.71万手，成交额2.73亿元。该股近半年内有股东持股变动，合计净减持695.0万股，股东增减持明细如下表：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2585468292","title":"11月24日微芯生物现12笔折价13.24%的大宗交易 合计成交4446.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585468292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585468292?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:59","pubTimestamp":1763978379,"startTime":"0","endTime":"0","summary":"证券之星消息，11月24日微芯生物发生大宗交易，交易数据如下：近三个月该股共发生32笔大宗交易，合计成交5.56万手，折价成交32笔。该股近期无解禁股上市。截至2025年11月24日收盘，微芯生物(688321)报收于27.19元，上涨1.53%，换手率1.92%，成交量7.82万手，成交额2.11亿元。该股近半年内有股东持股变动，合计净减持695.0万股，股东增减持明细如下表：该股最近90天内共有3家机构给出评级，买入评级3家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2585103472","title":"每周股票复盘：微芯生物（688321）股东减持1.18%且公司拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103472","media":"证券之星","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585103472?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:49","pubTimestamp":1763837350,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，微芯生物报收于26.78元，较上周的29.84元下跌10.25%。来自公司公告汇总：微芯生物拟取消监事会，由董事会审计委员会行使监事会职权。股本股东变化股东增减持11月19日微芯生物发布公告，股东博奥生物集团有限公司于2025年10月23日至11月19日期间合计减持482.95万股，占公司总股本的1.1843%。深圳微芯生物科技股份有限公司股东会议事规则股东会为公司最高权力机构，分年度与临时会议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2584187363","title":"11月20日微芯生物发生1笔大宗交易 成交金额2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584187363","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584187363?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:49","pubTimestamp":1763632153,"startTime":"0","endTime":"0","summary":"证券之星消息，11月20日微芯生物发生大宗交易，交易数据如下：大宗交易成交价格25元，相对当日收盘价折价9.26%，成交80万股，成交金额2000万元，买方营业部为华宝证券股份有限公司合肥潜山路证券营业部，卖方营业部为国投证券股份有限公司深圳宝安海秀路证券营业部。近三个月该股共发生20笔大宗交易，合计成交3.67万手，折价成交20笔。截至2025年11月20日收盘，微芯生物报收于27.55元，下跌1.25%，换手率2.38%，成交量9.7万手，成交额2.67亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000027038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2584914036","title":"11月19日微芯生物现4笔大宗交易 机构净买入1255.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584914036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584914036?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:34","pubTimestamp":1763544886,"startTime":"0","endTime":"0","summary":"证券之星消息，11月19日微芯生物发生大宗交易，交易数据如下：近三个月该股共发生19笔大宗交易，合计成交2.87万手，折价成交19笔。该股近期无解禁股上市。截至2025年11月19日收盘，微芯生物(688321)报收于27.9元，下跌1.86%，换手率1.99%，成交量8.1万手，成交额2.27亿元。该股近半年内有股东持股变动，合计净减持212.05万股，股东增减持明细如下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900028257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2583659935","title":"每周股票复盘：微芯生物（688321）现两日大宗交易合计超5300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583659935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583659935?lang=zh_cn&edition=full","pubTime":"2025-11-16 02:14","pubTimestamp":1763230454,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，微芯生物报收于29.84元，较上周的30.41元下跌1.87%。本周，微芯生物11月14日盘中最高价报30.8元。微芯生物当前最新总市值121.69亿元，在化学制药板块市值排名46/151，在两市A股市值排名1602/5165。交易信息汇总11月14日微芯生物发生6笔折价12.73%的大宗交易，合计成交2291.52万元。11月13日微芯生物发生9笔折价13.63%的大宗交易，合计成交3075.33万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2583571686","title":"11月14日微芯生物现6笔折价12.73%的大宗交易 合计成交2291.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583571686","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583571686?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:36","pubTimestamp":1763112963,"startTime":"0","endTime":"0","summary":"证券之星消息，11月14日微芯生物发生大宗交易，交易数据如下：近三个月该股共发生15笔大宗交易，合计成交2.06万手，折价成交15笔。该股近期无解禁股上市。截至2025年11月14日收盘，微芯生物(688321)报收于29.84元，下跌1.03%，换手率2.57%，成交量10.5万手，成交额3.16亿元。该股近半年内有股东持股变动，合计净减持212.05万股，股东增减持明细如下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2583903568","title":"11月13日微芯生物现9笔折价13.63%的大宗交易 合计成交3075.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583903568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583903568?lang=zh_cn&edition=full","pubTime":"2025-11-13 17:33","pubTimestamp":1763026396,"startTime":"0","endTime":"0","summary":"证券之星消息，11月13日微芯生物发生大宗交易，交易数据如下：近三个月该股共发生9笔大宗交易，合计成交1.18万手，折价成交9笔。该股近期无解禁股上市。截至2025年11月13日收盘，微芯生物(688321)报收于30.15元，上涨3.04%，换手率3.21%，成交量13.09万手，成交额3.92亿元。该股近半年内有股东持股变动，合计净减持212.05万股，股东增减持明细如下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300030384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2582866420","title":"每周股票复盘：微芯生物（688321）西格列他钠产能建设进展及临床研究突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2582866420","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582866420?lang=zh_cn&edition=full","pubTime":"2025-11-09 01:56","pubTimestamp":1762624573,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，微芯生物报收于30.41元，较上周的30.87元下跌1.49%。本周，微芯生物11月3日盘中最高价报31.75元。公司公告汇总深圳微芯生物科技股份有限公司于2025年10月30日召开第三届董事会第十七次会议，审议通过以集中竞价交易方式回购股份的议案，并于2025年11月1日披露预案。持股5%以上股东中仅博奥生物正在履行已披露减持计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900000328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2581905746","title":"微芯生物(688321.SH)：西奥罗尼胶囊治疗转移性胰腺导管腺癌临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2581905746","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581905746?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:26","pubTimestamp":1762421209,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微芯生物(688321.SH)公告，公司近日收到国家药品监督管理局药物审评中心签发的境内生产药品注册临床试验的《受理通知书》，公司自主研发的西奥罗尼胶囊治疗转移性胰腺导管腺癌的临床试验申请获得受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2581679791","title":"微芯生物：11月3日进行路演，国盛证券、方正证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2581679791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581679791?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:32","pubTimestamp":1762306360,"startTime":"0","endTime":"0","summary":"西奥罗尼一线方案初步显示了良好的抗肿瘤活性和可控的安全性。目前试验还在按照计划随访中。西达本胺2025年上半年同比增长15.1%,前三季度同比增速进一步加速到18.8%。西达本胺治疗结直肠癌适应症正处于III期临床阶段,其进展在国内同适应症中处于领先地位。目前已入组超300人,预期2025年内可完成大部分患者入组。该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500007030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0183","BK0276","BK0052","BK0188","601901","BK0012","BK0239","002670","688321","BK0028"],"gpt_icon":0},{"id":"2580473991","title":"每周股票复盘：微芯生物（688321）股东户数增25.25%，净利增238.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580473991","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580473991?lang=zh_cn&edition=full","pubTime":"2025-11-02 02:16","pubTimestamp":1762020973,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，微芯生物报收于30.87元，较上周的28.96元上涨6.6%。本周，微芯生物10月31日盘中最高价报32.0元。股本股东变化截至2025年9月30日，微芯生物股东户数为2.44万户，较6月30日增加4928.0户，增幅25.25%。业绩披露要点微芯生物2025年三季报显示，前三季度主营收入6.74亿元，同比上升40.12%；归母净利润7076.75万元，同比上升238.53%；扣非净利润5843.64万元，同比上升201.17%。涉及1名激励对象已获授但尚未行权的1.25万股股票增值权予以作废。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2580176964","title":"微芯生物（688321）2025年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2580176964","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580176964?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:50","pubTimestamp":1761951025,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期微芯生物发布2025年三季报。根据财报显示，微芯生物营收净利润同比双双增长。截至本报告期末，公司营业总收入6.74亿元，同比上升40.12%，归母净利润7076.75万元，同比上升238.53%。按单季度数据看，第三季度营业总收入2.68亿元，同比上升49.51%，第三季度归母净利润4117.53万元，同比上升508.54%。西奥罗尼一线方案初步显示了良好的抗肿瘤活性和可控的安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321"],"gpt_icon":0},{"id":"2579032454","title":"微芯生物(688321.SH)拟1000万元至1500万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2579032454","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579032454?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:55","pubTimestamp":1761904548,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微芯生物(688321.SH)发布公告，公司拟1000万元至1500万元回购股份，回购股份价格不超过47.46元/股，将用于员工持股计划或者股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2579531914","title":"10月31日微芯生物涨8.13%，中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579531914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579531914?lang=zh_cn&edition=full","pubTime":"2025-10-31 16:26","pubTimestamp":1761899181,"startTime":"0","endTime":"0","summary":"证券之星消息，10月31日微芯生物涨8.13%，收盘报30.87元，换手率7.23%，成交量29.49万手，成交额9.09亿元。重仓微芯生物的前十大公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A目前规模为0.61亿元，最新净值1.6711，较上一交易日下跌1.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100033785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2579970176","title":"图解微芯生物三季报：第三季度单季净利润同比增长508.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579970176","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579970176?lang=zh_cn&edition=full","pubTime":"2025-10-31 03:05","pubTimestamp":1761851128,"startTime":"0","endTime":"0","summary":"证券之星消息，微芯生物2025年三季报显示，前三季度公司主营收入6.74亿元，同比上升40.12%；归母净利润7076.75万元，同比上升238.53%；扣非净利润5843.64万元，同比上升201.17%；其中2025年第三季度，公司单季度主营收入2.68亿元，同比上升49.51%；单季度归母净利润4117.53万元，同比上升508.54%；单季度扣非净利润3811.63万元，同比上升460.23%；负债率54.42%，投资收益-1685.32万元，财务费用1507.62万元，毛利率87.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100003216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765028381539,"stockEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":-0.0931},{"period":"3month","weight":-0.2519},{"period":"6month","weight":0.2074},{"period":"1year","weight":0.3455},{"period":"ytd","weight":0.4882}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳微芯生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24446人(较上一季度增加25.25%)","perCapita":"16681股","listingDate":"2019-08-12","address":"广东省深圳市南山区西丽街道曙光社区智谷产业园B栋21F-24F","registeredCapital":"40780万元","survey":" 深圳微芯生物科技股份有限公司的主营业务是药物技术开发、相关成果商业应用；新药研究、开发、技术转让及其它有关的服务；新治疗技术研究、开发、技术转让及其它有关的服务；对外专利、技术的许可授权；药品的生产；保健食品生产经营。公司的主要产品是爱谱沙（西达本胺）、双洛平（西格列他钠）、西奥罗尼、CS23546、CS231295、CS32582、其他在研产品。","listedPrice":20.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微芯生物(688321)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微芯生物(688321)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微芯生物,688321,微芯生物股票,微芯生物股票老虎,微芯生物股票老虎国际,微芯生物行情,微芯生物股票行情,微芯生物股价,微芯生物股市,微芯生物股票价格,微芯生物股票交易,微芯生物股票购买,微芯生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微芯生物(688321)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微芯生物(688321)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}